UniProt ID | LAX1_HUMAN | |
---|---|---|
UniProt AC | Q8IWV1 | |
Protein Name | Lymphocyte transmembrane adapter 1 | |
Gene Name | LAX1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 398 | |
Subcellular Localization |
Cell membrane Single-pass type III membrane protein . |
|
Protein Description | Negatively regulates TCR (T-cell antigen receptor)-mediated signaling in T-cells and BCR (B-cell antigen receptor)-mediated signaling in B-cells.. | |
Protein Sequence | MDGVTPTLSTIRGRTLESSTLHVTPRSLDRNKDQITNIFSGFAGLLAILLVVAVFCILWNWNKRKKRQVPYLRVTVMPLLTLPQTRQRAKNIYDILPWRQEDLGRHESRSMRIFSTESLLSRNSESPEHVPSQAGNAFQEHTAHIHATEYAVGIYDNAMVPQMCGNLTPSAHCINVRASRDCASISSEDSHDYVNVPTAEEIAETLASTKSPSRNLFVLPSTQKLEFTEERDEGCGDAGDCTSLYSPGAEDSDSLSNGEGSSQISNDYVNMTGLDLSAIQERQLWVAFQCCRDYENVPAADPSGSQQQAEKDVPSSNIGHVEDKTDDPGTHVQCVKRTFLASGDYADFQPFTQSEDSQMKHREEMSNEDSSDYENVLTAKLGGRDSEQGPGTQLLPDE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
5 | Phosphorylation | ---MDGVTPTLSTIR ---CCCCCCCHHHHC | 18.98 | 26503514 | |
7 | Phosphorylation | -MDGVTPTLSTIRGR -CCCCCCCHHHHCCE | 24.79 | 23909892 | |
10 | Phosphorylation | GVTPTLSTIRGRTLE CCCCCHHHHCCEECC | 20.15 | 26503514 | |
14 | Ubiquitination | TLSTIRGRTLESSTL CHHHHCCEECCCCEE | 26.70 | 22505724 | |
15 | Phosphorylation | LSTIRGRTLESSTLH HHHHCCEECCCCEEE | 37.39 | - | |
15 | O-linked_Glycosylation | LSTIRGRTLESSTLH HHHHCCEECCCCEEE | 37.39 | OGP | |
18 | O-linked_Glycosylation | IRGRTLESSTLHVTP HCCEECCCCEEECCC | 31.56 | OGP | |
19 | O-linked_Glycosylation | RGRTLESSTLHVTPR CCEECCCCEEECCCH | 26.13 | OGP | |
20 | O-linked_Glycosylation | GRTLESSTLHVTPRS CEECCCCEEECCCHH | 30.11 | OGP | |
24 | O-linked_Glycosylation | ESSTLHVTPRSLDRN CCCEEECCCHHHCCC | 11.39 | OGP | |
71 | Phosphorylation | RKKRQVPYLRVTVMP HCCCCCCCEEEEEEH | 14.32 | 29083192 | |
74 | Ubiquitination | RQVPYLRVTVMPLLT CCCCCEEEEEEHHHC | 4.34 | 22505724 | |
75 | Phosphorylation | QVPYLRVTVMPLLTL CCCCEEEEEEHHHCC | 12.49 | 29083192 | |
90 | Ubiquitination | PQTRQRAKNIYDILP HHHHHHHHHHHHHCC | 46.17 | 22505724 | |
93 | Phosphorylation | RQRAKNIYDILPWRQ HHHHHHHHHHCCCHH | 13.31 | 28796482 | |
108 | Phosphorylation | EDLGRHESRSMRIFS HHCCCCCCCHHHEEC | 24.43 | 27251275 | |
112 | Methylation | RHESRSMRIFSTESL CCCCCHHHEECHHHH | 28.22 | 24395737 | |
115 | Phosphorylation | SRSMRIFSTESLLSR CCHHHEECHHHHHHC | 28.97 | 26657352 | |
116 | Phosphorylation | RSMRIFSTESLLSRN CHHHEECHHHHHHCC | 20.88 | 30108239 | |
118 | Phosphorylation | MRIFSTESLLSRNSE HHEECHHHHHHCCCC | 34.40 | 30108239 | |
121 | Phosphorylation | FSTESLLSRNSESPE ECHHHHHHCCCCCCC | 34.41 | 30108239 | |
184 | Phosphorylation | RASRDCASISSEDSH EECCCCCCCCCCCCC | 29.36 | 26657352 | |
186 | Phosphorylation | SRDCASISSEDSHDY CCCCCCCCCCCCCCC | 25.77 | 27251275 | |
187 | Phosphorylation | RDCASISSEDSHDYV CCCCCCCCCCCCCCC | 43.69 | 27251275 | |
190 | Phosphorylation | ASISSEDSHDYVNVP CCCCCCCCCCCCCCC | 17.76 | 26657352 | |
193 | Phosphorylation | SSEDSHDYVNVPTAE CCCCCCCCCCCCCHH | 6.62 | 12359715 | |
205 | Phosphorylation | TAEEIAETLASTKSP CHHHHHHHHHCCCCC | 20.71 | 26074081 | |
208 | Phosphorylation | EIAETLASTKSPSRN HHHHHHHCCCCCCCC | 39.21 | 26074081 | |
209 | Phosphorylation | IAETLASTKSPSRNL HHHHHHCCCCCCCCE | 29.90 | 26074081 | |
211 | Phosphorylation | ETLASTKSPSRNLFV HHHHCCCCCCCCEEE | 28.35 | 26074081 | |
213 | Phosphorylation | LASTKSPSRNLFVLP HHCCCCCCCCEEEEC | 40.67 | 26074081 | |
221 | Phosphorylation | RNLFVLPSTQKLEFT CCEEEECCCCEEEEE | 39.03 | 27251275 | |
222 | Phosphorylation | NLFVLPSTQKLEFTE CEEEECCCCEEEEEC | 27.99 | 27251275 | |
260 | Ubiquitination | DSLSNGEGSSQISND CCCCCCCCCCCCCCC | 33.71 | 29967540 | |
268 | Phosphorylation | SSQISNDYVNMTGLD CCCCCCCCCCCCCCC | 9.66 | 12359715 | |
294 | Phosphorylation | AFQCCRDYENVPAAD HHHHHCCCCCCCCCC | 7.05 | 28796482 | |
320 | Ubiquitination | VPSSNIGHVEDKTDD CCCCCCCCCEECCCC | 18.92 | 29967540 | |
336 | Ubiquitination | GTHVQCVKRTFLASG CCEEEEEEEEEECCC | 54.04 | 29967540 | |
338 | Phosphorylation | HVQCVKRTFLASGDY EEEEEEEEEECCCCC | 19.79 | 28348404 | |
342 | Phosphorylation | VKRTFLASGDYADFQ EEEEEECCCCCCCCC | 34.05 | 28348404 | |
345 | Phosphorylation | TFLASGDYADFQPFT EEECCCCCCCCCCCC | 16.17 | 29978859 | |
352 | Phosphorylation | YADFQPFTQSEDSQM CCCCCCCCCCHHHHH | 37.56 | 29978859 | |
370 | Phosphorylation | EEMSNEDSSDYENVL HHHCCCCCCHHHHHH | 20.94 | 30108239 | |
371 | Phosphorylation | EMSNEDSSDYENVLT HHCCCCCCHHHHHHH | 57.44 | 30108239 | |
373 | Phosphorylation | SNEDSSDYENVLTAK CCCCCCHHHHHHHHC | 16.02 | 19605366 | |
378 | Phosphorylation | SDYENVLTAKLGGRD CHHHHHHHHCCCCCC | 19.91 | 30108239 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
193 | Y | Phosphorylation | Kinase | SYK | P43405 | PSP |
193 | Y | Phosphorylation | Kinase | LCK | P06239 | PSP |
268 | Y | Phosphorylation | Kinase | SYK | P43405 | PSP |
268 | Y | Phosphorylation | Kinase | LCK | P06239 | PSP |
294 | Y | Phosphorylation | Kinase | SYK | P43405 | PSP |
294 | Y | Phosphorylation | Kinase | LCK | P06239 | PSP |
373 | Y | Phosphorylation | Kinase | SYK | P43405 | PSP |
373 | Y | Phosphorylation | Kinase | LCK | P06239 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of LAX1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LAX1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
STALP_HUMAN | STAMBPL1 | physical | 25416956 | |
CREB1_HUMAN | CREB1 | physical | 26186194 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-345 AND TYR-373, ANDMASS SPECTROMETRY. |